Emanuele Durante-Mangoni

Summary

Affiliation: Second University of Naples
Country: Italy

Publications

  1. doi Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment
    Emanuele Durante-Mangoni
    Second University of Naples Medical School, Department of Cellular and Molecular Biology, Federico II University Medical School, Naples, Italy
    Clin Infect Dis 49:498-506. 2009
  2. doi Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon
    Luigi E Adinolfi
    Internal Medicine and Hepatology, Facolta di Medicina e Chirurgia, Second University of Naples Medical School, Naples, Italy
    Intern Emerg Med 4:485-90. 2009
  3. doi Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
    Maria Giannouli
    Dipartimento di Scienze Mediche Preventive, Universita di Napoli Federico II, Via Pansini 5, Naples, Italy
    Int J Antimicrob Agents 39:58-63. 2012
  4. ncbi Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts
    Emanuele Durante-Mangoni
    Department of Internal Medicine, Second University of Naples Medical School, Napoli, Italy
    Antivir Ther 11:637-40. 2006
  5. doi Adefovir treatment for chronic hepatitis B in heart transplant recipients
    Emanuele Durante-Mangoni
    Internal Medicine Section, Department of Cardiothoracic Sciences, University of Naples SUN, and Unit of Transplant Medicine, Monaldi Hospital, Naples, Italy
    Clin Transplant 27:E282-8. 2013
  6. doi Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease
    Emanuele Durante-Mangoni
    Internal Medicine, University of Naples S U N, Naples, Italy
    Dig Liver Dis 43:411-5. 2011
  7. doi Clinico-pathological significance of hepatitis C virus core antigen levels in chronic infection
    Emanuele Durante-Mangoni
    Internal Medicine, University of Naples S U N, Naples, Italy
    J Med Virol 85:1913-8. 2013
  8. doi Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance
    Emanuele Durante-Mangoni
    Chair of Internal Medicine and Unit of Transplant Medicine, Second University of Naples, Monaldi Hospital, Naples, Italy
    Future Microbiol 6:407-22. 2011
  9. ncbi Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome
    Emanuele Durante-Mangoni
    Divisions of Internal Medicine and Hepatology, Second University of Naples Medical School, Napoli, Italy
    J Clin Gastroenterol 38:901-5. 2004
  10. doi Current trends in the management of cardiac implantable electronic device (CIED) infections
    Emanuele Durante-Mangoni
    Internal Medicine Section, Department of Cardiothoracic Sciences, University of Naples SUN, Naples, Italy
    Intern Emerg Med 8:465-76. 2013

Detail Information

Publications17

  1. doi Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment
    Emanuele Durante-Mangoni
    Second University of Naples Medical School, Department of Cellular and Molecular Biology, Federico II University Medical School, Naples, Italy
    Clin Infect Dis 49:498-506. 2009
    ..Analysis of hepatitis C virus (HCV) RNA kinetics during antiviral therapy may allow estimation of the probability of response...
  2. doi Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon
    Luigi E Adinolfi
    Internal Medicine and Hepatology, Facolta di Medicina e Chirurgia, Second University of Naples Medical School, Naples, Italy
    Intern Emerg Med 4:485-90. 2009
    ..e., 24% for cirrhotics and 50% for CHC, and 25% for genotype 1 and 60% for genotypes 2/3. The data indicate that Le-IFN-alpha plus ribavirin is a useful and effective treatment for CHC patients who are intolerant to peg-IFNs...
  3. doi Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
    Maria Giannouli
    Dipartimento di Scienze Mediche Preventive, Universita di Napoli Federico II, Via Pansini 5, Naples, Italy
    Int J Antimicrob Agents 39:58-63. 2012
    ..These data may have implications for the correct identification of cases with A. baumannii infection that would not benefit from addition of RIF to COL...
  4. ncbi Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts
    Emanuele Durante-Mangoni
    Department of Internal Medicine, Second University of Naples Medical School, Napoli, Italy
    Antivir Ther 11:637-40. 2006
    ..However, there are no data on the kinetics of granulocyte-colony stimulating factor (G-CSF), a major neutrophil growth factor, in this setting. We therefore evaluated G-CSF synthesis in CHC patients on peg-IFN-alpha treatment...
  5. doi Adefovir treatment for chronic hepatitis B in heart transplant recipients
    Emanuele Durante-Mangoni
    Internal Medicine Section, Department of Cardiothoracic Sciences, University of Naples SUN, and Unit of Transplant Medicine, Monaldi Hospital, Naples, Italy
    Clin Transplant 27:E282-8. 2013
    ..Our data suggest that ADV may be a safe and effective rescue treatment for heart transplant recipients with lamivudine-resistant chronic hepatitis B...
  6. doi Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease
    Emanuele Durante-Mangoni
    Internal Medicine, University of Naples S U N, Naples, Italy
    Dig Liver Dis 43:411-5. 2011
    ..Chronic hepatitis C patients with coexisting heart disease are often denied antiviral treatment due to safety concerns. However, this is not evidence-based...
  7. doi Clinico-pathological significance of hepatitis C virus core antigen levels in chronic infection
    Emanuele Durante-Mangoni
    Internal Medicine, University of Naples S U N, Naples, Italy
    J Med Virol 85:1913-8. 2013
    ..HCVcoreAg serum levels may be a useful tool to further the understanding of chronic hepatitis C pathobiology...
  8. doi Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance
    Emanuele Durante-Mangoni
    Chair of Internal Medicine and Unit of Transplant Medicine, Second University of Naples, Monaldi Hospital, Naples, Italy
    Future Microbiol 6:407-22. 2011
    ..baumannii and the epidemiology of drug-resistant A. baumannii in healthcare facilities. We will also discuss the therapeutic and infection control strategies for management of drug-resistant A. baumannii epidemics...
  9. ncbi Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome
    Emanuele Durante-Mangoni
    Divisions of Internal Medicine and Hepatology, Second University of Naples Medical School, Napoli, Italy
    J Clin Gastroenterol 38:901-5. 2004
    ..To assess the impact of interferon treatment on celiac disease onset in hepatitis C patients and to clarify its clinical relevance and outcome...
  10. doi Current trends in the management of cardiac implantable electronic device (CIED) infections
    Emanuele Durante-Mangoni
    Internal Medicine Section, Department of Cardiothoracic Sciences, University of Naples SUN, Naples, Italy
    Intern Emerg Med 8:465-76. 2013
    ..We discuss the current etiology and risk factors, and appraise the major diagnostic issues, describing our center's therapeutic approach. We also address the management of CIED infection complications. ..
  11. doi High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis
    Emanuele Durante-Mangoni
    Department of Internal Medicine, University of Naples S U N, Naples, Italy
    Clin Infect Dis 54:347-54. 2012
    ..Moreover, whether higher doses could be more effective but equally safe in this setting is currently unknown...
  12. ncbi Infection of intravascular prostheses: how to treat other than surgery
    Riccardo Utili
    Department of Cardiothoracic and Respiratory Sciences, Unit of Infectious and Transplant Medicine, Second University of Naples, Monaldi Hospital, Naples, Italy
    Int J Antimicrob Agents 30:S42-50. 2007
    ..Controlled studies are lacking and difficult to plan. Well-designed prospective studies may help to establish guidelines and reach a multidisciplinary consensus on the optimal therapeutic approach, and are therefore awaited...
  13. ncbi Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases
    Marie Francoise Tripodi
    Internal Medicine, Second University of Naples, Naples, Italy
    Int J Antimicrob Agents 30:537-40. 2007
    ..Combined use of the antimicrobials tested may provide good therapeutic options for OXA-58 carbapenemase-producing A. baumannii infections...
  14. ncbi Inherited hyper-homocysteinemia as a cause of nonbacterial thrombotic endocarditis
    Emanuele Durante-Mangoni
    Department of Cardiothoracic Sciences, University of Naples S U N and Unit of Infectious and Transplant Medicine, A O R N V Monaldi, Naples, Italy
    J Heart Valve Dis 20:232-3. 2011
    ..Despite high rates of valve disease, non-bacterial thrombotic endocarditis remains an uncommon condition, the individual susceptibility to which might be influenced by an inherited thrombophilic state...
  15. ncbi Do we still need the aminoglycosides?
    Emanuele Durante-Mangoni
    Unit of Infectious and Transplant Medicine, 2nd University of Naples, Monaldi Hospital, Naples, Italy
    Int J Antimicrob Agents 33:201-5. 2009
    ....
  16. ncbi Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe pneumocystis pneumonia in solid organ transplant recipients
    Riccardo Utili
    Unit of Infectious and Transplant Medicine, Department of Cardiothoracic and Respiratory Sciences, Second University of Naples and AORN V Monaldi, Naples, Italy
    Transplantation 84:685-8. 2007
    ..jiroveci in experimental animal models. We here report our preliminary clinical experience with caspofungin as an additional drug to the standard trimethoprim-sulfamethoxazole regimen...
  17. doi Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study
    Emanuele Durante-Mangoni
    Department of Cardiothoracic and Respiratory Sciences, Università di Napoli II, Naples, Italy
    Arch Intern Med 168:2095-103. 2008
    ..Elderly patients are emerging as a population at high risk for infective endocarditis (IE). However, adequately sized prospective studies on the features of IE in elderly patients are lacking...